相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines
Emanuele Petruzzella et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Biotin-tagged platinum(IV) complexes as targeted cytostatic agents against breast cancer cells
Nafees Muhammad et al.
CHEMICAL COMMUNICATIONS (2017)
Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator
Gregory Thiabaud et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Platinum(IV) anticancer prodrugs - hypotheses and facts
Dan Gibson
DALTON TRANSACTIONS (2016)
The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs
Simone Goeschl et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran et al.
CHEMICAL SCIENCE (2016)
Glutathione boosting the cytotoxicity of a magnetic platinum(IV) nano-prodrug in tumor cells
Zhenzhu Zhu et al.
CHEMICAL SCIENCE (2016)
A Photoactivatable Platinum( IV) Complex Targeting Genomic DNA and Histone Deacetylases
Jana Kasparkova et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(IV) prodrug with unique mode of action
Lili Ma et al.
CHEMICAL COMMUNICATIONS (2015)
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
Samuel G. Awuah et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2)
Cheng-Yu Tsai et al.
METALLOMICS (2015)
Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Daniel Yuan Qiang Wong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Qinqin Cheng et al.
CHEMICAL COMMUNICATIONS (2014)
Cellular Accumulation, Lipophilicity and Photocytotoxicity of Diazido Platinum(IV) Anticancer Complexes
Ana M. Pizarro et al.
CHEMMEDCHEM (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformations
Ying Song et al.
BIOCONJUGATE CHEMISTRY (2013)
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Wynand P. Roos et al.
CANCER LETTERS (2013)
Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation
Chee Fei Chin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes
Isolda Romero-Canelon et al.
METALLOMICS (2012)
Exploring the cellular accumulation of metal complexes
Cindy A. Puckett et al.
DALTON TRANSACTIONS (2010)
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Stephen B. Howell et al.
MOLECULAR PHARMACOLOGY (2010)
Expression, purification and use of recombinant annexin V for the detection of apoptotic cells
Susan E. Logue et al.
NATURE PROTOCOLS (2009)
Current status and future prospects for satraplatin, an oral platinum analogue
Hak Choy et al.
CLINICAL CANCER RESEARCH (2008)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin
GM Kolfschoten et al.
GYNECOLOGIC ONCOLOGY (2002)
Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C
M Amyere et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
分享论文
